Lucid Diagnostics (LUCD) Receivables - Other (2020 - 2023)

Lucid Diagnostics has reported Receivables - Other for 4 years, with the latest figure at $10.7 million in Q2 2023.

• For the quarter ending Q2 2023, Receivables - Other rose 340.39% year-over-year to $10.7 million; the trailing twelve-month figure through Jun 2023 stood at $10.7 million (up 340.39% YoY), and the FY2022 full-year result was $5.0 million, up 199.34% from the prior year.
• Receivables - Other for Q2 2023 stood at $10.7 million, up from $7.6 million in the prior quarter.
• The five-year high for Receivables - Other was $13.3 million in Q4 2020, with the low at $1.7 million in Q4 2021.
• Historically, Receivables - Other has averaged $6.1 million across 4 years, with a median of $5.8 million in 2022.
• Annual changes were most pronounced in 2021 — Receivables - Other tumbled 87.5% — and 2023, when it surged 340.39%.
• Lucid Diagnostics' Receivables - Other stood at $13.3 million in 2020, then plunged by 87.5% to $1.7 million in 2021, then surged by 199.34% to $5.0 million in 2022, then soared by 115.67% to $10.7 million in 2023.
• The last three Receivables - Other figures came in at $10.7 million (Q2 2023), $7.6 million (Q1 2023), and $5.0 million (Q4 2022), per Business Quant data.